Author: camel

SHANGHAI, Sep 1, 2025 - (ACN Newswire via SeaPRwire.com) - 28th August, The 2025 19th Frost & Sullivan Global Growth, Innovation and Leadership Summit and the 4th New Investment Event, hosted by Frost & Sullivan and co-organized by LeadLeo, was successfully held at the Jing'an Shangri-La Hotel in Shanghai from August 27 to 28, 2025. With the theme of "Intelligence Initiates a New Journey·Jointly Shaping Global Growth Engines", the Summit consists of an opening ceremony, eight parallel forums and a series of thematic activities, gathering over 200 heavyweight guests from home and abroad, more than 100 speeches/roundtable discussions, and attracting over 4,000 professional attendees.Frost & Sullivan has a history of nearly 30 years hosting Growth, Innovation and Leadership Summits worldwide, and this marks the 19th consecutive year of hosting the Summit in China. The 2025 Frost & Sullivan 19th GIL Summit featured in-depth discussions on hot topics such as AI and digital economy, new investments in life sciences, new consumption trends, ESG and new quality productive forces, high-quality development of listed companies, intelligent manufacturing going global and the global development of Chinese enterprises, jointly exploring new growth drivers, new markets and new tracks for China's economy in the new era. Focusing on cutting-edge industrial trends and capital movements, the Summit covers areas including macroeconomics, technological innovation, healthcare, energy storage, artificial intelligence and ESG practices, and released nearly 20 significant research findings on-site.Mr. David Frigstad, Global Chairman of Frost & Sullivan, highlighted the importance of the “Transformational Growth Journey,” which Frost & Sullivan defines as a seven-stage process to help companies navigate disruption and achieve sustainable success. He explained that the journey begins with understanding industry ecosystems across nine value chains, then leveraging data through the Growth Generator to enable rapid decision-making. Mr. David Frigstad emphasized that CEOs must view the world through a lens of prioritized growth opportunities and benchmark their organizations against global best practices. He also pointed to the Frost Radar as a tool for measuring future growth potential, built on both execution and innovation. Finally, Mr. David Frigstad underlined the role of community and collaboration, noting that true transformation requires openness to partnerships, new ideas, and global perspectives.Mr. Aroop Zutshi, Global President and Managing Partner of Frost & Sullivan, centered his speech on "Empowering Enterprises' Transformational Growth Journey", delivering an in-depth sharing focusing on global economic changes and corporate development, illuminating the growth path for enterprises seeking breakthroughs. He pointed out that the global economy is currently experiencing an unprecedented wave of change, and most enterprises are trapped in transformation dilemmas. The root causes lie in the difficulty in responding to change, missing hidden strategic opportunities and lacking a clear transformation framework. Only by taking proactive actions and focusing on strategic priorities can enterprises gain a firm foothold in the market reshuffle. To address the transformation challenges of enterprises, Mr. Aroop Zutshi proposed the "Top 5 Strategic Imperatives", including: 1. Transformation; 2. Ecosystem; 3. Growth Generator; 4. Growth Opportunities; 5. Frost Radar, Best Practices and Companies to Action, forming a systematic solution to support enterprises' transformational growth.Mr. Aroop Zutshi also detailed the six phases of Frost & Sullivan's "Growth Pipeline Engine", from growth audit and opportunity screening to strategy implementation and dynamic optimization, forming a interlocking systematic growth process to ensure that corporate growth is implementable and sustainable. Facing the Intelligence Revolution that began in 2023, he emphasized that this round of revolution is different from the Agricultural Revolution and the Industrial Revolution. By leveraging intelligent AI architectures, enterprises can deeply integrate deep web data, internal enterprise data and real-time public information. Only by equipping themselves with adaptive systems can enterprises seize technological dividends and occupy competitive high grounds. This sharing not only pointed out a way for enterprises to break through from "survival" to "development", but also conveyed clear growth value: by unifying team goals, stimulating innovation vitality and transforming strategies into practical actions, enterprises can not only avoid the risks of change, but also enhance their future growth potential, achieve sustainable high-quality development in the era of the Intelligence Revolution, and inject strong momentum into industrial transformation.Dr. Neil Wang, Global Partner and Greater China Chairman of Frost & Sullivan, stated that the theme of the Frost & Sullivan Summit has always centered on growth, innovation and leadership, adding value to enterprises, empowering industries and contributing to the national socio-economic development. He pointed out that the long-term, sustained and steady growth of China's economy is one of the greatest positives for the world. Frost & Sullivan not only studies the current growth of China's economy, but also focuses on predicting the future. At this Summit, Frost & Sullivan once again updated and released the White Paper on China's Industrial Development Trends in the Next 50 Years (4th Edition), hoping to help enterprises better grasp market opportunities and cope with challenges. According to his introduction, since entering China nearly 30 years ago, Frost & Sullivan has not only served a large number of innovative technology enterprises, but also actively engaged in technological innovation, such as proposing the concept of "AI + HI" (Artificial Intelligence + Human Intelligence) to empower the transformation and upgrading of traditional industries. Dr. Neil Wang believes that the core competitiveness of an enterprise lies in the leadership of entrepreneurs. The mission of Frost & Sullivan China is to convey China's growth, innovation, and leadership to the world, enabling the world to more clearly understand China's value and helping China accelerate its embrace of global opportunities.About Frost & SullivanFrost & Sullivan, the Transformational Growth company, enables clients to accelerate their growth and achieve best-in-class positions in growth, innovation, and leadership. The company’s Growth Pipeline as a Service provides the CEO’s Growth Team with transformational strategies and best-practice models to drive the generation, evaluation, and implementation of powerful growth opportunities. Let us be your growth coach on this transformational journey, as we actively support you in fostering collaborative initiatives within your industry’s ecosystem.About Frost & Sullivan GIL SummitThe Growth, Innovation and Leadership Summit founded by Frost & Sullivan has a history of nearly 30 years and is held in more than 20 countries and regions around the world. It has attracted in-depth participation from a large number of Global 1000 companies, top domestic and foreign financial institutions and other leading enterprises, helping them identify opportunities, continuously innovate, accelerate growth and gain a leading position in an increasingly complex and changing world. Since its launch in China in 2008, the Frost & Sullivan GIL Summit has been held for the 19th time. It has become an important platform for outstanding domestic enterprises, the investment community and regulatory authorities to exchange successful experiences and jointly explore development directions, as well as a key window for the world to understand China's cutting-edge development trends.Media ContactFrost & SullivanShanghai, ChinaRachel ZhangE: rachel.zhang@frostchina.comT: +86 021-3209-6800W: http://www.frostchina.com/ Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Sep 1, 2025 - (ACN Newswire via SeaPRwire.com) - On August 29, Everest Medicines (1952.HK) announced its interim results for the six months ended June 30, 2025. The Company’s total revenue for the first half of 2025 reached RMB 446 million, representing 48% year-over-year growth, while operating expenses as a percentage of revenue decreased by 40.1 percentage points, reflecting strong operational efficiency. Non-IFRS loss narrowed by 31%, and gross margin excluding non-cash items was 76.4%. As of the end of June, the Company maintained a solid cash balance of RMB 1.6 billion. Additionally, with the successful completion of a share placement on August 1, which generated net proceeds of HK$1.553 billion, Everest’s total cash position increased further, providing a strong foundation for commercialization expansion and R&D investment. Supported by the excellent performance of its core products, Everest remains confident in achieving its full-year revenue guidance of RMB 1.6 to 1.8 billion and expects to turn operating cash flow positive in Q4.BOCOM International released its latest report today, noting that the strong sales performance of Everest Medicines’ Nefecon(R) far exceeded expectations. The institution significantly raised its revenue forecasts for 2026–2027 and lifted its target price to HK$84. The report highlighted a rich pipeline of catalysts from the second half of 2025 through 2026, including the approval, commercialization, and reimbursement negotiations of etrasimod in China, as well as potential BD opportunities for the Company’s proprietary pipeline. BOCOM International believes the current valuation remains attractive and reiterated its “Buy” rating.“In the first half of 2025, Everest Medicines accelerated its transformation into a leading global biopharmaceutical company by deepening our ‘dual-engine’ strategy. We have built a commercialization platform anchored by two blockbusters covering high-potential markets and powered by the in-house discovery and clinical translation of in vivo CAR-T and mRNA therapeutic cancer vaccine platforms.” said Rogers Yongqing Luo, Chief Executive Officer of Everest Medicines.Core Products Deliver Strong Growth, Driving Commercial Platform MomentumNEFECON(R), the blockbuster product in the renal portfolio, delivered particularly strong performance. As the first and only fully approved etiological treatment for IgA nephropathy (IgAN) in China, the United States, and Europe, NEFECON(R) generated revenue of RMB 303 million in the first half of 2025, representing 81% year-over-year growth. However, our first half revenue was artificially low due to a supply constraint that was rooted in both strong market demand and a delay in regulatory approval of a supplemental application for production scale up designed to ensure supply stability. This has been fully resolved since our supplemental application was approved by the China CDE on Aug 1, 2025. Following the supplemental application was approved by the China CDE in August, supply capacity increased significantly. Cumulative sales from January to August reached RMB 825 million, including RMB 520 million in August alone, reflecting strong market demand. Full-year sales are expected to reach RMB 1.2–1.4 billion, with continued strong growth projected in 2026, potentially reaching RMB 2.4–2.6 billion.Another Core product XERAVA(R), As the world’s first fluorocycline antibiotic recorded RMB 143 million in the first half of 2025, up 6% year-over-year. In-hospital sales increased 37% year-over-year, driven by Everest’s core hospital strategy.Additionally, VELSIPITY(R) (etrasimod), a best-in-disease therapy for moderately to severely active ulcerative colitis (UC), is positioned as Everest’s next growth engine, with its NDA in mainland China expected to be approved in the first half of 2026. The localized production project for VELSIPITY(R) was officially launched at the Jiashan manufacturing site in March 2025, providing strong support for its future commercialization.Global Proprietary Pipeline Value Emerging，Strong Prospects for Blockbuster Potential Everest continues to focus on achieving key breakthroughs in its proprietary pipeline, while accelerating the clinical development and global expansion of innovative assets with global rights. EVER001 (civorebrutinib), the next-generation covalent reversible BTK inhibitor, has delivered encouraging Phase 1b/2a clinical data in primary membranous nephropathy (pMN). With potential applications in IgAN, minimal change disease (MCD), and FSGS, covering a patient population of more than 10 million worldwide, EVER001 represents a significant market opportunity, with projected global peak sales exceeding RMB 10 billion. A global Phase II basket trial is expected to be initiated in the first half of 2026.Leveraging its industry-leading mRNA therapeutic cancer vaccine platform and in vivo CAR-T platform, the Company is building a globally competitive R&D pipeline. EVM18, the in vivo CAR-T program, has completed multiple non-human primate (NHP) trials and achieved preclinical proof-of-concept, with first-in-human data expected by the end of 2025. EVM16, the personalized therapeutic mRNA cancer vaccine, has initiated its first-in-human trial in China, with patient dosing completed. In the investigator-initiated trial (IIT), dose escalation in the low- and mid-dose cohorts has been completed, with encouraging preliminary data observed. EVM14, an off-the-shelf tumor-associated antigen (TAA) vaccine, has received IND approval from the U.S. FDA and acceptance from China’s NMPA. The Phase I trial in the U.S. is currently underway, with first patient enrollment expected by September 2025. EVM15, the immune-modulatory cancer vaccine, has completed preclinical proof-of-concept and identified its clinical candidate.Strategic Repositioning to Bolster Global CompetitivenessDuring the reporting period, the Hong Kong Stock Exchange approved the removal of the “B” marker from Everest’s stock short name, reflecting recognition of the Company’s strong R&D pipeline, commercialization capabilities, and overall business fundamentals. In addition to the successful top-up placement, Everest invested approximately US$30.9 million in I-Mab (Nasdaq: IMAB) in August 2025. Following the transaction, Everest increased its ownership in I-Mab to approximately 16.1%, becoming its single largest shareholder, further strengthening its global presence in next-generation immuno-oncology therapies.Analysts noted that Everest’s “dual-engine” strategy is rapidly delivering results. On the one hand, the Company’s powerful commercial platform—anchored by NEFECON(R) and VELSIPITY(R) and supported by XERAVA(R), Cefepime-taniborbactam, EVER001, and other high-potential assets—is expected to generate synergies with total peak sales exceeding RMB 25 billion globally. On the other hand, Everest’s in vivo CAR-T and mRNA therapeutic cancer vaccine platforms provide significant long-term growth potential through global development and partnership opportunities. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Sep 1, 2025 - (ACN Newswire via SeaPRwire.com) - Black Spade Capital Limited (“Black Spade”) recently held a private meeting with Ark Invest.Mr. Dennis Tam, President and CEO of Black Spade, met with Ms. Catherine Wood, CEO and CIO of Ark Invest, to discuss key trends in AI, robotics, blockchain applications, energy storage, and cellular sequencing. Ms. Wood expressed optimism about AI and robotics, noting these technologies will not just displace jobs but also create new opportunities. She highlighted the potential of blockchain and space exploration, emphasizing that the world is advancing toward a more innovative and interconnected future. Mr. Tam advised family offices to focus on digital assets, AI, and robotics-focused funds, stocks, and ETFs, as these sectors are set to drive global economic growth. He explained that industries integrating these innovations will see significant productivity gains, boosting competitiveness in a fast-paced market. He encouraged family offices to adjust their asset allocations based on risk tolerance and invest in these emerging fields to support development and pursue higher returns. Ms. Wood predicted strong growth in cryptocurrencies, forecasting Bitcoin could reach USD 1.5 million and Ethereum USD 166,000 around 2030. She expressed confidence in the long-term potential of digital assets. Mr. Tam added that digital assets are becoming a mainstream asset class, with growing adoption by banks and government institutions creating strong momentum. In summary, Black Spade Capital urges family offices to act swiftly by investing in funds, stocks, and ETFs linked to AI, robotics, and digital assets. These sectors will drive economic and technological development, improve efficiency in traditional industries, and offer significant returns, positioning investors at the forefront of the next technological revolution.Photo caption:From the left: Mr. Dennis Tam, President and CEO of Black Spade and Ms. Catherine Wood, CEO and CIO of Ark InvestAbout Black Spade Capital LimitedBlack Spade Capital Limited is an established family office that manages the private investments of Mr. Lawrence Ho. Headquartered in Hong Kong, its global portfolio consists of a wide spectrum of cross-border investments as it consistently seeks to add new projects and opportunities to its investment mix. Black Spade’s investment strategy maximizes coverage of geographic regions and sectors whilst maintaining a portfolio of diversified asset classes, ranging from equity, fixed income, medical technology, leisure and culture, green energy, real estate to Pre-IPO investments. In August 2023, Black Spade Acquisition Co, a blank check company (SPAC) sponsored by Black Spade, completed a US$23 billion business combination with VinFast Auto Ltd. In 2024, Black Spade listed its second SPAC, Black Spade Acquisition II Co, which completed a business combination with global media and entertainment powerhouse The Generation Essentials Group in about 9 months in June 2025.Media Enquiries:Strategic Financial Relations Limited Vicky LeeTel: +852 2864 4834Email: vicky.lee@sprg.com.hkIris Au YeungTel: +852 2114 4913Email: iris.auyeung@sprg.com.hkWebsite: www.sprg.com.hk Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

NEW YORK, Sept 1, 2025 - (ACN Newswire via SeaPRwire.com) - me88 news, a dedicated sports journalism platform, announced its official launch today, designed to provide comprehensive coverage and expert analysis across four key competitive disciplines: Formula 1, E-sports, Badminton, and Martial Arts.Addressing the Information Gap in Sports MediaThe launch of me88 news responds to the growing demand for specialized sports content that goes beyond surface-level reporting. Unlike traditional sports platforms that prioritize click-driven headlines, me88 news focuses on delivering substantive analysis, technical breakdowns, and exclusive behind-the-scenes content that enhances readers' understanding of competitive sports."The sports media landscape is saturated with recycled content and sensational headlines," said Owen Parker at me88 news. "Our platform represents a commitment to journalism that respects both the intelligence of our audience and the complexity of modern competitive sports."Comprehensive Multi-Sport Coverageme88 news provides specialized reporting across four distinct sporting categories:Formula 1: Technical analysis covering paddock politics, pit lane strategies, and the engineering innovations that define modern motorsportE-sports: Tournament coverage, player profiles, and analysis of the rapidly evolving digital athletics landscapeBadminton: In-depth coverage of one of the world's most physically demanding racket sports, featuring tactical analysis and athlete profilesMartial Arts: Comprehensive reporting spanning traditional disciplines to modern competitive fighting, honoring both heritage and contemporary innovationReal-Time Global CoverageThe platform operates with around-the-clock reporting capabilities, ensuring readers receive timely updates regardless of global time zones. Features include live event coverage, instant post-competition analysis, and multimedia content including highlight reels and exclusive interviews.Beyond breaking news, me88 news offers editorial content designed to foster informed discussion within the sports community, including opinion pieces, feature stories, and long-form investigations into the human stories behind athletic achievement.Industry Positioning and Future Outlookme88 news enters a competitive digital sports media market with a differentiated approach focused on quality over quantity. The platform's launch reflects broader industry trends toward specialized content and expert analysis as audiences increasingly seek authoritative sources for sports information.The company plans to expand coverage areas and enhance multimedia offerings as the platform develops its audience base and establishes its position within the sports media ecosystem.About me88 newsme88 news is a sports journalism platform dedicated to providing comprehensive coverage and analysis across multiple competitive disciplines. Through strategic partnerships and expert-driven content, me88 news serves sports enthusiasts seeking in-depth analysis that enhances their understanding and appreciation of competitive athletics.Media ContactCompany: me88 newsContact: Media TeamWebsite: https://me88news.com/ Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Sep 1, 2025 - (ACN Newswire via SeaPRwire.com) - 29 August, Anton Oilfield Services Group ("Anton" or "the Group"; stock code: 3337), a world leading independent oilfield technical services provider, is pleased to announce its unaudited condensed consolidated interim results for the six months ended 30 June 2025 ("the Reporting Period" or "the Period").During the first half of 2025, the Group achieved operating revenue of approximately RMB2.63 billion (all figures in RMB), representing a year-on-year increase of 20.9%. Net profit reached RMB166 million, up 49.0% year-on-year, while profit attributable to equity holders of the Company amounted to approximately RMB165 million, marking a 55.9% year-on-year growth. Anton's operational efficiency saw significant improvement, with robust operating cash flow performance. Net cash inflow during the period reached RMB370 million, an increase of RMB24.3 million year-on-year. Average days sales outstanding stood at 162 days, a reduction of 22 days compared to the same period last year.Establishing a new business model: "Integrated Service Company " + "Technical Service Provider"During the reporting period, in its mature business areas of oilfield technical services and oilfield management services, Anton continued to strengthen reservoir enhancement capabilities, further highlighting the advantages of its asset-light technical service model. This drove steady development in oilfield technical services, with revenue reaching RMB 1.21 billion, a year-on-year increase of 22.9%, accounting for 45.8% of total revenue. Concurrently, oilfield management services maintained steady growth, generating revenue of RMB 1.00 billion during the period, an increase of 11.2%, as the company progressively replicates its successful business model into new global markets. In new business ventures, the company actively expanded in three key directions: oil and gas development, natural gas utilization, and AI-enabled solutions. Oil and gas development operations strengthened exploration and development capabilities while accelerating progress at the Dhufriyah. Natural gas utilization achieved breakthroughs in Southeast Asia through onshore natural gas commercialization projects (OPF) . AI-empowered services have gained initial scale, covering the entire application chain from artificial intelligence to subsurface data management and surface asset integrity, comprehensively enhancing the quality and efficiency of oil and gas development.Through long-term business model upgrades, Anton has preliminarily established a commercial model that integrates technical services with technical operators. The technical service operator model represents an integrated approach deeply merging technical services with operator responsibilities. Unlike traditional oil companies acquiring operating rights through capital investment, Anton secures field operating rights through technical contributions. This model is particularly suited to mature and marginal fields requiring enhanced development efficiency. By tightly integrating technical services with production operations, it achieves efficient development and maximizes asset value, while maintaining light-asset operations, low costs, high efficiency, and strong cyclical resilience.Expanding Global Markets, Unlocking New Market OpportunitiesAnton's ongoing global market expansion has unlocked new market opportunities, becoming a core driver of performance growth. In the first half of 2025, overseas markets generated revenue of RMB 1.68 billion, representing an 11.2% increase from RMB 1.511 billion in the same period last year. Overseas revenue maintained a high proportion of 63.8% of the Group's total income. The Iraq market, as a core market where the Group has deepened its presence, has achieved comprehensive deployment, forming a synergistic business ecosystem of technical services, oilfield management, and oil and gas development. This has further enhanced market influence and driven scaled development; during the period, it contributed revenue of RMB 1.447 billion, a year-on-year increase of 16.6%, accounting for 55.0% of the Group's total revenue.In Sarawak, Malaysia, the group successfully secured its first onshore natural gas commercialization project (OPF Project), establishing a crucial foothold for deeper market penetration in Southeast Asia. In the Kuwait market, the company's completion tools successfully passed pre-qualification. Capitalising on Kuwait's first comprehensive opening of its technical services market, the company is preparing bids for various projects to cultivate new growth drivers. Concurrently, Anton will continue to cultivate global markets including the Middle East, Africa, Central Asia and Southeast Asia, steadily expanding its business footprint.The Group recorded robust new orders in the first half of the year, with total new contracts signed amounting to approximately RMB 4.75 billion. Overseas markets contributed RMB 3.12 billion in new orders, accounting for 65.7% of the Group's total new orders. As of 30 June 2025, the Group's order backlog reached approximately RMB 16.35 billion. This substantial order pipeline provides a solid foundation for sustained, high-speed growth in future performance.Deepening Global Management, Accelerating Digital and Intelligent TransformationTo underpin the deepening implementation of its global strategy, the Group has intensified management optimisation efforts. Anton positions Dubai as its global headquarters and operational centre, Egypt as its human resources hub, India as its supply chain procurement centre, mainland China as its technology and raw materials resource centre, and Hong Kong as its financial centre. Leveraging the strengths of each location, these centres collectively support the Group's global expansion. During the first half of the year, the Group inaugurated its new Hong Kong office and established Anton Treasury Company to enhance capital management efficiency and strengthen the integration of China's market with global resources. In accelerating digital and intelligent development, Anton leveraged AI and data-driven approaches to empower management efficiency, achieving full-chain connectivity of core business process data.Outlook:Advancing Long-Term Strategic Goals with a Refined PositioningAnton's long-term vision is to become a leading global green energy technology services company. Currently positioned as an integrated service provider and technical service operator, it delivers efficiency enhancement solutions for oil and gas development. Leveraging China's unique advantages and global footprint, Anton aims for rapid growth to become an industry innovation leader.Driving Long-Term Growth Through Early Indicator ManagementThe company employs data-driven early-stage indicator management to achieve long-term objectives, encompassing six critical steps: expanding market reach through client resource development; identifying market opportunities via demand research; securing high-quality projects through project initiation and feasibility studies; securing orders through project sales; building service capacity for existing orders through rapid project production and construction; and converting existing orders into revenue through operational execution. This early-stage indicator management enhances the predictability of orders and revenue while providing greater assurance of market opportunities and business prospects.Continuously Focusing on Core Markets while Further Expanding Global Markets and its Product PenetrationThe company will maintain its focus on mature markets such as Iraq, deepening potential and seizing core market opportunities to drive scaled growth. Concurrently, it will build long-term reserves for expanding into emerging global markets including Gulf States, Central Asia, Southeast Asia, and Africa. Furthermore, by benchmarking against global industry leaders and adopting innovative business models, the company will comprehensively enter new market tiers. Oilfield technical services centre on reservoir enhancement, integrated field management offers distinctive capabilities, oil and gas development establishes a technical service operator model, while natural gas utilization targets vast, commercially untapped global reserves. AI-enabled solutions and platform collaboration drive comprehensive operational efficiency gains across the oil and gas sector.Enhance Shareholder Returns through Efficient OperationsThe company will pursue rapid, asset-light growth through platform-based, ecosystem-driven and innovative business models. By operating with efficiency, it will continuously enhance profitability and generate healthy cash flow, thereby establishing a solid foundation for shareholder returns. It remains committed to its dividend and share buyback policies, employing multiple measures to consistently create value for shareholders.About Anton Oilfield Services GroupEstablished in 1999 and listed on the Hong Kong Stock Exchange in December 2007 (Stock Code: HK. 3337), Anton Oilfield Services Group is a globally leading integrated service provider for enhancing oil and gas resource development efficiency, a technical services operator, and an innovation pioneer. Our long-term vision is to become a premier global green energy technology services provider for the new era. Addressing the sustainable development needs of the future oil and gas industry, we deliver personalized, comprehensive, and integrated solutions tailored to the diverse requirements of our oilfield clients, maximizing the value of their assets. With Dubai serving as our global headquarters and operational centre, Egypt as our human resources hub, India as our supply chain procurement centre, Mainland China as our technology and raw materials resource centre, and Hong Kong, China as our financial centre, we leverage distinctive Chinese strengths to integrate global resources and conduct efficient global management and operations. Our business spans over 30 countries and regions, primarily emerging markets including China, Iraq, Chad, and Kazakhstan, forming a rapid-response global service support system.This press release is issued on behalf of Anton Oilfield Services Group by Zhixin Investor Relations Consultant Limited.For enquiries, please contact:Zhixin Investor Relations Consultant Limited.Mr Jason Wang / Ms Sally ZhaoTel: (0755) 2394 1306 / (0755) 2360 3515Email: wangxiaoxiang@zhixincaijing.com / zhaohongxia@zhixincaijing.co Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Sep 1, 2025 - (ACN Newswire via SeaPRwire.com) - Champion Real Estate Investment Trust (“Champion REIT” or the “Trust”) (Stock Code: 2778) is pleased to announce that the Trust has been assigned its first “A” Issuer Rating with a stable outlook by Japan Credit Rating Agency, Ltd. (“JCR”) and Rating & Investment Information Inc. (“R&I”).The dual recognition from Japan’s two leading credit rating agencies underscores the Trust’s strong reputation in the capital markets, and reinforces investor confidence in its steady and prudent financial management.Ms Christina Hau, Chief Executive Officer of Champion REIT, said, “We are honoured to receive ‘A’ credit ratings with stable outlooks from both JCR and R&I. This recognition testifies to our prudent financial management, stable capital structure and the enduring quality of our landmark assets in prime locations. We will continue to stay agile in our business and financial strategies to deliver sustainable value to our unitholders and stakeholders in a dynamic market environment.” JCR said, “The ratings positively reflect the Trust’s stable business model focused solely on property leasing and management, high-quality portfolio, financial soundness supported by conservative leverage control, and long-term management track record of overcoming past market cycles.”R&I said, “The rating reflects the excellent portfolio comprised of trophy properties located in central Hong Kong, significantly low level of leverage and track record of long-term and solid performance for approximately 19 years.”About Champion REIT (2778)Champion Real Estate Investment Trust is a trust formed to own and invest in income-producing office and retail properties. The Trust focuses on Grade A commercial properties in prime locations. It currently offers investors direct exposure to nearly 3 million sq. ft. of prime office and retail floor area. These include two Hong Kong landmark properties, Three Garden Road and Langham Place, as well as a joint venture stake in 66 Shoe Lane in Central London. The Trust has been awarded the top five-star rating by GRESB since 2023. Champion REIT is managed by Eagle Asset Management (CP) Limited, a member of the Great Eagle Group.Website: www.championreit.comAbout Japan Credit Rating Agency Ltd. (JCR)Established in 1985, JCR is a leading credit rating agency in Japan, and an expert of credit risk analysis. JCR widely provides accurate evaluations on sustainable finance, and is an evaluation organization that contributes the most to “overcoming environmental and social issues and realizing a sustainable society”, one of the most important global issues. JCR is certified by the European Securities and Markets Authority (ESMA), and recognized as eligible ECAI by the Hong Kong Monetary Authority (HKMA).About Rating & Investment Information Inc. (R&I)R&I is Japan's leading rating agency with the largest market share in Japanese bond market. R&I provides credit ratings, research, and investment information services to support sound investment decisions and promote transparency in the financial markets. It is recognized by Japan’s Financial Services Agency (FSA) and the Hong Kong Monetary Authority (HKMA). Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Sep 1, 2025 - (ACN Newswire via SeaPRwire.com) - On August 31, 2025, Shoucheng Holdings Limited (0697.HK, “Shoucheng Holdings”) announced that its wholly owned subsidiary, Shouwo Investment Holdings Co., Ltd., plans to establish Shoucheng Robotics Advanced Materials Industrial Co., Ltd. (“Advanced Materials Company”). The new company will focus on R&D and industrialization of key upstream materials for the robotics industry, marking a solid step in Shoucheng’s full-value-chain robotics strategy.The Advanced Materials Company will primarily target core materials such as electronic skin, tendon cables, and lightweight PEEK composites, while advancing investment, joint R&D, and incubation projects. Through deep collaboration with research institutions and industry partners, the company aims to address critical performance and cost gaps in robotics, drive breakthroughs in materials technology, and accelerate application deployment. This initiative is not only an important extension of Shoucheng’s upstream robotics layout but also a vital step toward completing its full ecosystem led by humanoid robots.According to Shoucheng Holdings’ 2025 interim report, the company is progressively building a comprehensive robotics industry chain that spans upstream materials, midstream systems and key components, and downstream applications:Upstream: With the Advanced Materials Company as its vehicle, Shoucheng will focus on electronic skin, tendon cables, and lightweight PEEK materials, engaging in investment, joint R&D, and industrial incubation. This effort not only addresses performance and cost-control bottlenecks but also provides strong support to upstream and downstream players, enhancing the competitiveness of the entire ecosystem.Midstream: Leveraging its industrial funds, Shoucheng has systematically invested in leading firms including Unitree, Galbot, Noetix Robotics, Galaxea-AI, and Booster Robotics, covering humanoid robot systems, motion control, perception, and intelligent algorithms. With capital empowerment and industrial synergy, these companies are accelerating technological breakthroughs and commercialization.Downstream: The company actively promotes robotics applications in smart mobility, healthcare, and intelligent manufacturing. Examples include the Chengdu ICD autonomous charging station jointly developed with Wisson Technology, and the Shurui surgical robot—deployed at Peking University Shougang Hospital—which has already performed clinical surgeries. Meanwhile, Shoucheng will officially open its first “Robotics 4S Store” at Beijing Rongshi Plaza during the National Day holiday, showcasing and selling robotics products to the public. This retail hub will integrate experience, application, and consumer interaction, bridging the gap from industrialization to consumer adoption.Shoucheng Holdings stated that going forward, it will leverage full-chain synergies across capital, technology, and application scenarios to further enhance its integration capability and influence in the global robotics industry. The company aims to support China’s robotics sector in achieving independent control and accelerated development, contributing to the country’s ambition of becoming a global technology leader.Posted by All Way Success Company Limited for Shoucheng Holdings www.shouchengholdings.com [HKSE:0697, FRA:SHVA, OTCPK:SHNHF] Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Aug 31, 2025 - (ACN Newswire via SeaPRwire.com) - Hong Kong-listed Shoucheng Holdings Limited (0697.HK) released its interim results for 2025. Driven by its dual-engine strategy of “Asset Operations + Asset Finance,” the company delivered a balanced performance combining steady growth with forward-looking strategic initiatives: first-half revenue reached HK$731 million, up 36% year-on-year; net profit attributable to shareholders was HK$339 million, up 30%; and gross profit stood at HK$295 million, up 26%.Meanwhile, the company continued its high-dividend tradition. According to the public roadshow on August 31, Shoucheng is expected to distribute a total dividend of HK$1.159 billion for FY2025, with a dividend yield of nearly 8%, ranking among the highest in the Hong Kong market. In addition, more than 40 million shares have been repurchased. Financially, Shoucheng holds over HK$8 billion in cash, has fully repaid all bank loans to reduce financing costs, and maintains a gearing ratio of just 7.9%. With its robust capital structure, the company has a solid safety cushion and strong capacity to capture new investment opportunities under current market conditions.I. Solid Financials and Strong Shareholder ReturnsIn the first half of 2025, Shoucheng maintained steady growth in both revenue and profit while continuously strengthening its capital structure. Total assets reached HK$14.35 billion, and the company has maintained its AAA credit rating for three consecutive years from China Chengxin International and United Credit Ratings.Kang Yu, General Manager of Shoucheng’s Board Office, noted in an interview:“We aim not only to create long-term growth potential for our shareholders—Shoucheng’s businesses are at their best stage in history, and we are just setting sail—but also to ensure certainty of shareholder returns. This year alone, dividends have already reached nearly HK$1.2 billion, and continuous share buybacks highlight management’s firm confidence in Shoucheng’s long-term prospects.”The company’s high-dividend and buyback policy reflects a long-term win-win commitment to investors.Notably, the company’s asset finance business delivered outstanding performance, with first-half revenue reaching HK$220 million, a surge of 69% year-on-year, making it a key growth engine driving overall results. Through the establishment of a RMB10 billion Infrastructure Real Estate Equity Investment Stabilization Fund in partnership with China Life, Shoucheng Holdings has continued to deepen its presence in the REITs market, growing into one of the largest industrial investors in the country. The company has successively completed strategic allotment investments in Nanfang Range / Wanguo Data Center REIT, Sunlon REIT, and Huadian Clean Energy REIT, covering key areas such as data centers and clean energy. This has enabled Shoucheng to build a systematic layout across all types of infrastructure assets and establish a complete closed-loop capability from fund investment to asset exit.At the same time, Shoucheng Holdings has also achieved remarkable results in equity investments. Through its multiple industrial funds, the company has invested in leading robotics firms including Unitree, Galbot, Galaxea-AI, X Square Robot, Noetix Robotics, Booster Robotics, and Narwhal Robotics. Previously, Shoucheng secured outstanding results from investments in Li Auto, Horizon Robotics, Zhaogang.com, StarVision, and Silan Microelectronics. Its equity funds had already achieved more than three times book returns earlier this year, delivering impressive exit proceeds. These success stories validate Shoucheng’s forward-looking investment vision in industrial research and also set a solid benchmark for expected returns from its future robotics investments.Kang Yu, General Manager of the Board Office, commented: “We believe that as the robotics industry enters the stage of scaled deployment, the leading companies invested by Shoucheng will deliver higher capital returns and strategic value for the Group.”II. Accelerating the Robotics Strategy: Building the Full Industrial Value ChainIf the financial data demonstrates Shoucheng Holdings’ solid fundamentals, then its robotics business represents the company’s most imaginative growth trajectory for the future. As one of the first listed companies in China to systematically invest in the robotics sector, Shoucheng is accelerating its transformation from a pure investor into a full-chain service provider.Through the RMB10 billion Beijing Robotics Industry Development Investment Fund and its affiliated funds, the company has invested in dozens of leading enterprises such as Unitree, Galbot, Noetix Robotics, Galaxea-AI, and Booster Robotics, covering humanoid robots, core components, and other critical fields. This investment matrix has firmly positioned Shoucheng Holdings at the forefront of the embodied intelligence industry.Notably, the company has also strengthened its presence in the upstream of the robotics value chain. Recently, Shoucheng announced the establishment of Shoucheng Robotics Advanced Materials Industrial Co., Ltd. through its wholly owned subsidiary Shouwo Investment, focusing on advanced materials such as electronic skin, tendon cables, and lightweight PEEK composites. This initiative not only fills critical gaps in the value chain but also enhances the technological performance of portfolio companies in tactile sensing, flexible control, and lightweight design, further improving the full-chain ecosystem represented by humanoid robots.On the application side, the company is driving robotics into real production and everyday life scenarios. Its wholly owned subsidiary, Beijing Shoucheng Robotics Technology Industrial Co., Ltd., is deploying robotics across multiple dimensions. By providing sales agency, leasing, and secondary development services, the company is creating a “Didi-style” supply-demand platform for the robotics sector, facilitating efficient collaboration across the industry chain. Kang Yu noted that Shoucheng will further build a robotics application platform, positioning itself as a comprehensive solutions provider. Acting as a “chain leader,” the company will integrate industry resources, centralize procurement of high-quality products from ecosystem partners, and expand from B2B to B2C and C-end markets, fully unlocking the potential of robotics applications while delivering strong returns to shareholders.Shoucheng’s robotics industrialization strategy has already shown early results. Its strategic cooperation with IAT Automobile Technology Co., Ltd. means robots will be deeply integrated into automotive production lines, intelligent testing, and electrification processes, driving “Robotics + Automobiles” cross-sector synergies. In smart mobility, the Chengdu ICD autonomous charging station co-developed with Wanxun Technology has already been put into operation, enabling large-scale robotic applications in new energy vehicle services. In healthcare, Peking University Shougang Hospital has introduced the SurRui surgical robot developed by a partner within Shoucheng’s robotics ecosystem, marking an accelerated path toward commercialization of domestic surgical robots and breakthroughs in high-end medical equipment.In August this year, at the inaugural World Humanoid Robot Games held in Beijing, multiple companies invested by Shoucheng Holdings made a collective appearance, winning 37 medals (including 12 gold, 14 silver, and 11 bronze). This fully showcased the rapid progress of Chinese robotics companies in motion control and intelligent interaction. At the same time, the company launched the “Shoucheng Robotics Experience Store” outside the “Ice Ribbon” venue, which became one of the most popular exhibition areas during the event. The store not only displayed humanoid and service robots to the public but also provided interactive experiences, helping robots move from professional arenas into everyday life.Looking further ahead, Shoucheng Holdings is exploring the “Robotics 4S Store” model, with plans to create a retail service system that integrates exhibition, sales, maintenance, and customer experience. Kang Yu noted:“At this year’s robot games, our 200-square-meter pop-up store alone generated over RMB 30,000 in daily sales, which strongly reflects public enthusiasm and expectations for robotics applications. Just like new energy vehicles once required 4S channels to popularize, robots will also need service networks to truly enter thousands of households. In the future, we hope individuals, families, and enterprises alike can experience, try on, test, purchase, or lease various robots in-store while enjoying comprehensive after-sales and maintenance services. Through this model, we aim to bridge the ‘last mile’ of the robotics industry and drive robots into daily life.”III. Broad Prospects for Robotics Applications: China’s Soil Nurtures Global LeadersGlobally, the robotics industry is shifting from “running, jumping, and performing” to “understanding, reasoning, and working.” According to GGII (Gaogong Industry Institute), the global humanoid robot market is expected to reach approximately RMB 6.3 billion in 2025, nearly RMB 64 billion by 2030, and potentially exceed RMB 400 billion by 2035. Kang Yu believes that within the next three to five years, robots will see large-scale adoption in industrial manufacturing, healthcare, smart elderly care, and consumer services.She added: “China not only has policy support and capital investment but also possesses unique application scenarios globally, providing the best soil for rapid commercialization of robotics. Shoucheng Holdings’ mission is to combine capital with scenarios to truly bring cutting-edge technologies into scaled application.”Shoucheng Holdings is a dedicated cultivator in this fertile soil. The company has built a complete industry chain layout covering upstream–midstream–downstream:Upstream: Through its wholly owned subsidiary, it established Shoucheng Robotics Advanced Materials Industrial Co., Ltd., focusing on core materials such as electronic skin, tendon cables, and lightweight PEEK, while jointly developing and incubating new technologies to fill gaps in the robotics value chain.Midstream: Through its affiliated industrial funds, Shoucheng has invested in leading companies including Unitree, Galbot, Noetix Robotics, Galaxea-AI, and Booster Robotics, covering humanoid robot systems and critical components.Downstream: Driving scenario applications, Shoucheng has already enabled robotics adoption in real-world environments such as IAT Automobile Technology’s production lines, the Chengdu ICD autonomous charging station with Wanxun, Peking University Shougang Hospital’s surgical robotics, and its Robotics Experience Store. The company is also exploring a “Robotics 4S Store” model.Kang Yu emphasized: “Our mission is to combine capital, materials, technology, and application scenarios to truly scale up frontier technologies.”IV. Outlook: Marching Toward the HK$100 Billion MilestoneAs AI and robotics enter a new stage of application realization, Shoucheng Holdings stands at the forefront of industrial takeoff. With solid asset operations, forward-looking industrial deployment, and consistent shareholder returns, the company is steadily advancing toward its long-term goal of HK$100 billion market capitalization.Kang Yu concluded: “Robotics are the intelligent infrastructure of a new era. Shoucheng Holdings aims not only to be an investor but also a full-chain driver and service provider. We are confident in leveraging the synergy of capital, materials, and application scenarios to lead China’s robotics industry to new heights.”Posted by All Way Success Company Limited for Shoucheng Holdings www.shouchengholdings.com [HKSE:0697, FRA:SHVA, OTCPK:SHNHF] Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Aug 30, 2025 - (ACN Newswire via SeaPRwire.com) - GF Securities Co., Ltd. (“GF Securities”)or the “Company”, together with its subsidiaries within the scope of its consolidated financial statements (“subsidiaries”), the “Group”) announced its interim results for 2025. In the first half of 2025, the Company proactively integrates into the national development, in-depth development of the “Five Major Areas", sticking to its functional positioning, and actively serves the real economy for both quantity and quality. The Company achieved steady progress in all areas of the work with main operating indicators in the forefront of the industry. During the Report Period, total revenue and other income of the Company was RMB19,916 million and net profit attributable to owners of the Company was RMB6,470 million.As one of the first batch of pilot comprehensive management brokerages selected by the CSRC, GF Securities possesses licenses for a full range of services involved in four business segments, including investment banking, wealth management, trading and institution, and investment management. The Group has successively set up futures subsidiaries, public fund subsidiaries, private fund subsidiaries, alternative investment subsidiaries and asset management subsidiaries. With its unique value concept and pragmatic entrepreneurial style, the Company has built up a full-service chain with comprehensive layout and strong strength. In respect of regional development, the Company based in Greater Bay Area and serves the whole country, connecting domestically and internationally, forges a leading national brokerage with a long-term vision and an open mind. Against this backdrop, the Company has maintained main operating indicators ranking among the top securities companies in China for many consecutive years.Steady Operations as the Core, Balanced Growth Across the Four Major Business SegmentsGF Securities has a complete business system and a balanced business structure. During the Reporting Period, all four of the Company’s business segments both achieved steady growth.The Transformation of Wealth Management continues to advance deeply. The Company equipped with excellent financial product research, sales capabilities and professional asset allocation capabilities and more than 4,600 securities investment consultants, ranking No. 2 in the industry (in terms of parent company caliber). The Company is committed to providing precise wealth management services for different types of customers. It has become a first-class trustworthy wealth management institution. As of the end of June 2025, the total balance of financial products sold by Company on a commission basis exceeded RMB300.0 billion, representing an increase of approximately 14.13% as compared to the end of last year; the balance of margin financing and securities lending of the Company was RMB103.638 billion, with a market share of 5.60%. From January to June 2025, the turnover of the Company’s SSE and SZSE stock and funds amounted to RMB15.14 trillion (bilateral statistics), representing a year-on-year increase of 62.12%.The Investment Banking business maintained its steady and robust development. During the Reporting Period, the Company completed 5 A share equity financing projects with a lead underwritten amount of RMB15.622 billion; and completed 2 listings on the NEEQ. Meanwhile, the Company completed 11 overseas equity financing projects which were Hong Kong IPO projects, with an issue size of HK$42.773 billion, and its equity financing business in Hong Kong ranked fourth among Chinese-based securities companies in terms of the total issuance size of IPOs and refinancing projects equally distributed among all underwriters (Source: Bloomberg, Statistics of the Company). In respect of debt financing, the Company acted as the lead underwriter for 419 tranches of bonds, with a lead underwritten amount of RMB153.721 billion. In respect of Chinese offshore bond business, 29 bonds were issued with an underwritten amount of US$49.865 billion. During the Reporting Period, the Company completed three projects in major asset restructuring and financial advisory business that had industry and regional influence, and the transactions in which the Company acted as listed company’s independent financial advisor involved a total transaction amount of approximately RMB2.272 billion; and won the award of the 2025 New Fortune Best M&A Investment Bank.The Investment Management business maintained its leading position. In the first half of 2025, the Group carries out public fund management business through its non-wholly owned subsidiary, GF Fund, and investee company, E Fund, collectively managed over RMB3,600 billion in the public funds assets. They ranked third and first respectively in the industry in terms of the size of public funds under management excluding monetary funds, respectively (Source: Wind, Statistics of the Company). The specific asset management schemes under the wholly-owned subsidiary GF Asset Management increased by 39.49% compared to the end of 2024. Another wholly-owned subsidiary, GF Futures, managed 63 asset management schemes with a total asset under management of RMB15.856 billion. The wholly-owned private fund subsidiary GF Xinde focused on such industries as AI, robotics, biomedicine, intelligent manufacturing, new energy and corporate services. As of the end of June 2025, its paid-in funds under management reached approximately RMB19.5 billion. Overseas, the Group’s wholly-owned subsidiary GFHK was one of the first batch of financial institutions in Hong Kong with the PRC background granted with RQFII qualification. Its subsidiary GF Investments (Hong Kong) managed four equity investment fund products focusing on high-end manufacturing, TMT, big consumption and biomedical industries. Several investment projects have exited by way of mergers and acquisitions or been listed on the stock exchanges in Hong Kong, the United States and other regions.The Trading and Institutional Services business demonstrated steady improvement. As a primary dealer of OTC derivatives business, the market making business of the Company continued to be in the first echelon, and officially launched the market-making business in the STAR Market and the BSE. During the Reporting Period, providing market-making services for more than 900 funds and all ETF options of the SSE and SZSE, market-making services for CSI 300 stock index options and CSI 1000 stock index options of the China Financial Futures Exchange, as well as market-making services for 2 STAR Market-listed companies, 1 BSE-listed company, and 40 NEEQ companies. During the Reporting Period, the Company issued 51,508 private equity products through the China Securities Inter-agency Quotation System and OTC market, with a total amount of RMB501.180 billion, and the scale of FICC investment business continued to grow with multiple strategies. As of the end of June 2025, 3,707 products were under the custody of the Company and fund operation outsourcing services were provided for 4,380 products. The wholly-owned subsidiary GF Qianhe focused on hard technology, AI+, advanced manufacturing, healthcare, special opportunity investment and other major fields, with a total of 330 projects invested.Investor-First Strategy, Enhancing Integrated Financial ServicesGF Securities insists on being investor-oriented, and continues to improve the quality and efficiency of services to different customer groups such as individual investors, institutional investors, and corporate customers by honing its comprehensive financial service capabilities with the full life cycle across the entire business chain, and rewards investors with outstanding results.In respect of individual investors, the Company adhered to a “customer-centric” business philosophy and unswervingly accelerated its transformation into a buy-side investment adviser while strengthened its diversified asset allocation capabilities. During the Reporting Period, the Company closely followed its main tone for high-quality development and its digitalization and platform based strategies. It focused on the key development direction for “high-quality customer base and efficient online operation” of the wealth brokerage business, seized any market opportunities to capture the customers’ needs, and continued to consolidate its customer base and standardize operations; and continued to diversify its product supply system and transaction supporting tools, so as to improve the integrated service system for institutional customers to enhance customer experience. The Company also comprehensively developed its artificial intelligence service functions, coordinated to promote the application and empowerment of the AI-enabled wealth brokerage model, and continued to enhance the comprehensive capacity of serving residents’ wealth management.In respect of institutional clients, the outstanding research capacity of the Company enjoys a high reputation in the industry and received numerous honors. It has won awards from mainstream organizations and ranked among the top: Best Analyst of Securities Times, Best Analyst of New Fortune, Golden Bull Award for China Securities Industry Analysts, etc. As of the end of June 2025, the Group’s equity research covered 28 industries and 997 A-share listed companies in Mainland China, and 207 overseas listed companies.During the Reporting Period, the Company actively promoted the adoption of digital intelligence in research business, further explored AI applications in intelligent investment and research functions, establishing a multi-platform, multi-channel and multi-dimensional customer service system by leveraging the GF research portal and mini programs. At the same time, concentrating on the main theme of Chinese-style modernization and focusing on the development of new quality productive forces, the Company successfully organized large-scale investment strategy conferences such as the “AI+ Industry Forum” and “Dialogue with Leadership”, establishing a platform for exchanges between listed companies and institutional investors.In respect of corporate clients, the Company focused on serving the high-quality development of the real economy, strengthened industrial resources accumulation and professional capabilities building in key sectors, and endeavored to develop into an industrial investment bank and a technology investment bank. As of the end of June 2025, the Company sponsored a total of 47 companies listed on the market as the lead brokerage, of which 82.98% were “specialized, sophisticated, distinctive and innovative” enterprises. Meanwhile, the Company accurately served the national strategies, such as scientific and technological innovation, green and low carbon, and made continuous breakthroughs in the innovation of bond products. During the Reporting Period, the Company acted as the lead underwriter for 66 tranches of various science and technology innovation bonds with an underwritten amount of RMB25.663 billion; acted as the lead underwriter for 11 tranches of various low-carbon transformation and green bonds with an underwritten amount of RMB3.850 billion; and acted as the lead underwriter for 4 tranches of rural revitalization bonds with an underwritten amount of RMB1.4 billion. In respect of Chinese offshore bond business, 29 bonds were issued with an underwritten amount of US$49.865 billion.Moreover, the industrial research institute of the Company continued to build the ecosystem of production, learning, research, investment and financing, focused on the key racing tracks to deepen the building of industrial ecosystem, empowered the development of various business segments of the Company, and provided various research consulting services to support policy formulation and industrial planning of governments at all levels. The Company also deepened the connection with key scientific research academic institutions, scientist groups, professional equity investment institutions, enterprises of various sectors and government departments, and established a cooperation mechanism for transforming scientific research results and coordinating industrial incubation, playing the role of a bridge in process of empowering technology with finance and transforming into productivity.Anchor in Regional Development, Deliver Full Life Cycle Financial ServicesThe Guangdong-Hong Kong-Macao Greater Bay Area is one of the four major bay areas in the world with the highest degree of opening-up and the most resilient market economy in China, playing an important strategic position in the overall development of the country. GF Securities has fully supported the implementation of major national regional strategies by being deeply rooted in Guangdong-Hong Kong-Macao Greater Bay Area, the forefront of China’s reform and opening-up, enriched customer foundation, and facilitated technology, capital and virtuous industry circles.As a professional capital market institution growing up in the Greater Bay Area, the Company has advantages in industrial research and capital operation, actively explores a new model of industry-finance integration and supports the transformation and upgrading of regional economies and industries by deepening the integration of local industry and capital and building industrial fund in various forms; gives full play to the role of capital market in value discovery and resource allocation, and realizes financial services in industries with the full life cycle by building industrial clusters through direct financing.At the end of June 2025, the Company had 356 branches and business departments nationwide, with a presence in 31 provinces, municipalities, and autonomous regions across the PRC. Its total number of business outlets in the nine cities of the Pearl River Delta in the Guangdong-Hong Kong Macao Greater Bay Area ranked No. 1 in the industry. The extensive market provided wide market reach for the Company’s business development and laid important support for customer accumulation and service.On the front of main operating development, GF Securities has adopted a strategy deeply rooted in regional development, reinforcing its foundation through steady and sustainable growth. During the Reporting Period, the Company actively fulfilled its role as a “service provider” for direct financing and a “gatekeeper” for the capital market. It deepened business cultivation in key areas, consolidated its market position and competitiveness in the Greater Bay Area, and expanded its presence in key areas within the Yangtze River Delta region. It continued to advance an integrated domestic and international strategy, improved mechanisms for cross-border talent development and collaboration, and enhanced the efficiency of cross-border operations as well as overall service capabilities to effectively support Chinese enterprises in their overseas expansion. Centering its strategy around the guidance of national industrial, financial, and regional development policies, the Company held the AI-themed merger and acquisition forum of the Guangdong Capital Market M&A Alliance, and endeavored to set up a merger and acquisition business ecosystem to provide customers with multi-level and all-round comprehensive services, promoting the orderly circulation of assets and capital.2025 marks not only the concluding year of the 14th Five-Year Plan, but also a pivotal starting point for laying the groundwork of the 15th Five-Year Plan. GF Securities will adhere to the main line of high-quality development, actively integrating into China's overall development, and focusing its efforts on implementing the financial “Five Major Areas”. The Company will continue to solidify its outstanding location advantage in the Guangdong-Hong Kong-Macao Greater Bay Area and beyond, deploying long-term strategies with elevated standards and strengthening its core businesses—contributing to the high-quality economic and social development. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Aug 29, 2025 - (ACN Newswire via SeaPRwire.com) - Gome Retail Holdings Limited (Stock code: 493.HK, "Gome Retail" or the "Company", together with its subsidiaries, “the Group”) announced its unaudited six-month results for the six months ended June 30, 2025 (the "Reporting Period").Focusing on the main industry to consolidate the border, breakthrough in debt resolutionIn the first half of 2025, the external environment was complex and severe. Structural contradictions persisted in China, while the industry where the Group belongs showed some signs of recovery, they were still in the bottomingout phase. However, since the fourth quarter of last year, national policies have become more proactive, with the introduction of a number of important stimulus policies. The effects of these policies were further realised in the first half of 2025. Benefiting from these policy initiatives, the Group’s revenue, profit, and other indicators improved significantly during the Reporting Period. During the Reporting Period, the Group recorded sales revenue of RMB297 million, a year-on-year increased by 75.74%; Gross profit was RMB20 million, a year-on-year increased by 11.11%; and loss attributable to owners of the parent during the Reporting Period was RMB1,346 million, a year-on-year decreased by 69.63%.In the first half of 2025, China’s economic growth met expectations. Policy initiatives continued to strengthen, with stimulus measures such as trade-ins and equipment upgrades continuing and expanding in the consumer sector. This has led to a rebound in the growth of durable goods consumption, including home appliances, and initial signs of a bottoming-out recovery in the industry. The Group accelerated its efforts in transformation projects and emerging businesses, including franchise model innovation and car experience centers, achieving progress in each area during the Reporting Period. Debt disposal efforts progressed in an orderly manner during the Reporting Period, the Group actively negotiated debt solutions with various creditors, including financial institutions, suppliers, and convertible bondholders. The Group gradually reduced its debt burden through debt-to-equity swaps, franchise expansion, discussions with banks on debt disposal solutions, and the disposal and sale of non-core assets，and achieved significant progress during the Reporting Period, laying a solid foundation for continued operations.Continuing to promote the asset-light model, the strategic results are gradually showing Gome Retail adheres to a strategy of "asset-light, operations-focused, strong control, and replicability," focusing on sales, revenue, and positive cash flow. Leveraging its supply chain advantages, it optimizes its operating model and details, empowering franchise opportunities. Regarding franchising, the Group continues to expand brand licensing opportunities to franchisees, focusing on supply chain model innovation to assist franchisees in market expansion, avoid high self-development costs, and precisely allocate resources to brand building and user experience. Regarding franchising, the Group continues to strengthen its equity-based partnership model, primarily through the "single-store franchising" format, with the " urban experience Center" at its core, to build a extensive franchise network for the home appliance and related products. Through supply chain empowerment, asset-light operations, and refined management, the Groups is creating a new model for scenario-based digital marketing.New business launch accelerates, with the Car Experience Center officially operationalGome Retail is actively cultivating new growth points. The first Gome Car Experience Center Xibahe Store officially opened on April 29, 2025, marking the Group's official entry into the automobile distribution field. The center has already drawn dozens of mainstream new energy marques, offering early proof that its intensive operating model can lower single store costs and sharpen customer acquisition. Several automakers have responded with concrete partnerships.Looking ahead, the year 2025 marks the final year of China’s 14th Five-Year Plan. Moreover, the Central Politburo has decided to commence the formulation of the 15th Five-Year Plan ahead of schedule in the second half of this year, in order to accelerate the recovery of domestic demand. As a result, it is expected that there will be more substantial policy support at the national level in the coming months.Gome Retail management said: “Despite the significant challenges the Group has faced in recent years, management has remained proactive and unwavering in its efforts. Through persistent dedication, the Group achieved its first signs of performance recovery during the Reporting Period and made substantive progress in strategic transformation and the exploration of new business areas. In the second half of the year, we will continue to devote our full efforts to overcoming current challenges as swiftly as possible, thereby laying the groundwork for a sustained recovery.”About GOME RETAIL HOLDINGS LIMITEDGOME RETAIL HOLDINGS LIMITED was listed on the Hong Kong Stock Exchange in July 2004 (Stock Code: 493HK). Founded in 1987 in China, GOME is committed to building China's leading technology-based, experiential, entertainment-oriented and socialized home-life technology retailer. With the strategy of "Home Living", Gome Group focuses on retailing of electrical appliances and consumer electronics products, and builds a closed-loop ecosystem for the entire product line.Please visit our website for more information: www.gome.com.hkIssued by EVER BLOOM (HK) COMMUNICATIONS CONSULTANTS GROUP LIMITED for and on behalf of GOME Retail Holdings Limited. For further information, please contact: EVER BLOOM (HK) COMMUNICATIONS CONSULTANTS GROUP LIMITEDMr Matthew Li / Ms Isla GuTel: (852) 3468 8874 Fax:(852) 2111 1103Mail: Matthew.li@everbloom.com.cn/ jin.gu@everbloom.com.cn Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HIGHLIGHTS:- The Group’s gross billings amounted to approximately RMB1,705.4 million, representing an increase of approximately 83.3% from approximately RMB930.5 million for the Corresponding Period.- The Group’s total revenue was approximately RMB2,099.7 million, representing an increase of approximately 133.8% from approximately RMB898.1 million for the Corresponding Period.- The profit attributable to Shareholders of the Group was approximately RMB865.4 million, as compared to the net loss attributable to Shareholders of approximately RMB174.2 million for the Corresponding Period.- Taking into account the financial and cash flow positions of the Group, the Board recommends the payment of an interim dividend of approximately HKD238.9 million for the six months ended June 30, 2025, representing HKD0.51 per share (in cash).HONG KONG, Aug 29, 2025 - (ACN Newswire via SeaPRwire.com) - JF SmartInvest Holdings Ltd (the “Company” ; together with its subsidiaries, the "Group" or “we”) is pleased to announce its unaudited consolidated interim results for the six months ended June 30, 2025 (the “Reporting Period”). During the Reporting Period, the Company sustained robust operations and realized a revenue of approximately RMB2,099.7 million, representing a YOY growth of approximately 133.8%. Profit attributable to Shareholders amounted to approximately RMB865.4 million, representing a YOY turnaround to profit from the net loss attributable to Shareholders of approximately RMB174.2 million in the Corresponding Period, and an increase of approximately RMB1,039.6 million in the Reporting Period. These fully demonstrate the effective strategy execution and high market adaptability of the Company.The Company places great emphasis on Shareholders returns. Taking into account the financial and cash flow positions of the Group, the Board recommends the payment of an interim dividend of approximately HKD238.9 million for the six months ended June 30, 2025, representing HKD0.51 per share (in cash). Maintaining a prudent dividend policy not only reflects the strong profitability of our core business and our ample cash flows, but also highlights our strong sense of responsibility and commitment to Shareholders returns. Since the listing of the Company in 2023, the Company has made cash dividend payments for consecutive years with increasing dividend payout ratio. Notably, the dividend payout ratio reached 50.3% for 2024.Developing a dimensional product matrix for revenue diversificationLeveraging on the synergy and conversion of the products under our existing four main product lines, we further strengthened our core advantages in “intelligent algorithms + professional investment research + ecosystem services”, drove the transformation of our next-generation stock investing assistants from “feature-focused” to “experience-orientated”, and continued to improve our digital financial infrastructure, thereby facilitating the development of personalized and inclusive financial services.We consolidated the foundation of our large-amount software products and delivered our expertise in investment advisory services to ensure robust and strong performance of the core business. Empowered by AI technology, we fully delivered our expertise in investment advisory by newly launching 8 stock monitoring indicators and the “FinSphere SmartInvest” quantitative product that further strengthened our AI service capabilities. At the same time, we advanced the framework construction of our Stock Learning Machine through forming the three main matrices of “content, tool and trading” with focus on six core modules such as courses, live streaming and tools, to create a comprehensive learning platform. During the Reporting Period, It underwent 5 major version iterations and over 200 feature optimizations.In addition, we refined our small-amount series products to enhance our product strengths and operational capabilities and accelerate the platform development of our App. We built a Chief IP ecosystem integrating K-line chart analysis and expert insights,that enabled us to precisely distribute contents through a user tagging system. We upgraded our market information by enriching data such as capital flow trends, Hong Kong and US stocks, and launched new features of stock monitoring and portfolio watchlist. We optimized our information page with an infinite content feed, personalized recommendations, and improved visual hierarchy. Meanwhile, we also expanded multiple distribution channels including app stores, and refined our marketing strategies through data analysis. By sorting out the bottlenecks in registered users’ activation, we implemented tiered strategies to enhance utilization rates. Our homepage was dynamically optimized to enhance the attractiveness of its first screen. These measures accelerated the development of our App platform, broadened our user coverage and product exposure, increased the trustworthiness and stickiness of our App and created a closed loop of “content nurtures users and trust drives conversion”.Adhering to Artificial Intelligence + Investment Advisory strategy and refining our “1+N” investment research systemWith focus on the “buyer-side investment advisory” service, we vigorously developed “AI+” and further strengthened our “1+N” investment research system to fully penetrate our investment research into businesses and processes, so as to professionally support our customers in creating long-term value. We continued to make significant investment and effort in research and development. During the Reporting Period, we invested approximately RMB147 million in R&D activities. Meanwhile, as of the end of the Reporting Period, we had 139 software copyrights and patents on product features, big data, and AI, that represented an increase of 21 YOY.We actively explored the all-round empowerment of AI in the securities sector. We practiced “AI + Investment Advisory” providing a one-stop intelligent investment research platform which consolidates the core strengths of comprehensive stock analysis, multi-dimensional stock profiling, and diverse quantitative stock selection, and delivers professional investment research capabilities in an accessible, personalized, and empathetic manner that suits different types of investors. Meanwhile, considering compliance as our lifeline, we built an intelligent compliance and risk control platform covering the entire business process that creates a closed compliance loop of complete activity logging, data traceability, risk blocking, intelligent quality inspection and human-machine collaboration. During the Reporting Period, the cumulative number of behavioral monitoring tasks conducted by our “AI Monitoring Officer” increased by over approximately 77% as compared with 940 million in the Corresponding Period, and our “AI Inspection Officer” for content quality inspection assisted in nearly 2.2 million review tasks, reflecting that full coverage has been basically achieved.Based on our “1 research institute and N business lines” investment research system with our JF Financial Research Institute at the core, we continued to refine our underlying business competitiveness in securities investment advisory. Guided by the principle of “conducting higher-dimensional research and providing lower-dimensional services”, the institute is committed to developing a domestically leading and characteristically distinctive investment research service platform in China to provide long-term and steady, systematic, trustworthy and professional research services for investors. As of the end of the Reporting Period, the institute established a pyramid team structure consisting of 4 experts, 9 super-IPs and 128 professionals. It studied over 4,000 companies in over 20 industries.Refining traffic operation on MCNs with AI empowerment to build a high-quality traffic systemBy capitalizing on our refined traffic operations and realizing traffic reuse, we effectively expanded our business scale and improved our profit margins through optimization of operational efficiency. During the Reporting Period, using AIGC to optimize content production, we enhanced the production efficiency of premium contents. Moreover, using Douyin as our primary channel, we established a multi-platform layout with focus on Kuaishou, Xiaohongshu and Bilibili, to extend the boundaries of traffic operation scenarios. As of the end of the Reporting Period, the Company operated 994 MCN accounts on different internet platforms. These accounts attracted approximately 63.06 million followers, representing an increase of 17.47 million as compared with the Corresponding Period.At the same period, we actively practiced investor education for greater brand influence. We joined the Investor Education Alliance of China Fund and opened a Yinghua account to provide inclusive, systematic and differentiated investor education content for investors, contributing to the long-term development of stock investing theory. We exclusively sponsored Chinese Business Network’s live broadcast of the Berkshire Hathaway Annual Shareholders Meeting for the sixth consecutive year. Through “Buffett and Seven Lunches”, we helped investors build cognitive understanding of investing, and we specially organized a US study tour, bringing nearly a hundred investors to attend the meeting in person so that they could directly ask the stock god questions about value investing. This created a dialogue between the general investors and the iconic investor, aiming to provide them with more diverse and down-to-earth investment advice and forward-looking insights. We also attended “Financial Powerhouse”, a featured program of China Central Television, to provide deep explanation and analysis of the paradigm shift of the Company’s “AI + Investment Advisory” services empowered by fintech.Business outlookThe chairman of the Board and chief executive officer of JF SmartInvest Holdings Ltd, Mr. Chen Wenbin said: "Consistently adhering to the concepts of rational investing, value investing and long-term investing, we insisted on adopting a customer-centric approach to develop a dimensional product system and continuously improve our services. Looking forward to future, we, as a next-generation stock investing assistant, will continue to strengthen our competitiveness, solidify our market leadership and strive to make investing and wealth management easier yet more professional, and enhance the happiness of investment and wealth management. "About JF SmartInvest Holdings Ltd (Stock Code: 9636)JF SmartInvest Holdings Ltd is a new generation stock investment assistant. The Company is engaged in the provision of equity investment instruments, securities investment advisory, investor education and other services to individual investors. The products include stock quote software, stock learning machine, Stock Navigator, Super Investor and Jiuyao Stocks. The Company adopts the technology + investment research model, develops JF Robo-Advisor, FinSphere Agent, FinSphere Report and other products based on artificial intelligence (AI) and big data technology, which are applied to the industry in terms of innovative practice and scenario application.For enquiries, please contact:Financial PR (HK) LimitedEmail: ir@financialpr.hkTel: 852 2610 0846Fax: 852 2610 0842 Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

RESULTS HIGHLIGHTS:- The Revenue for the six months ended 30 June 2025 (“the Period”) was approximately HK$1,834.8 million, representing an increase of approximately 7.8% as compared with the same period last year. The increase in the revenue was mainly due to the continued organic growth of the Group (mainly in Europe and Australia regions) and accelerated by our acquisition of Hexa Ceram Company Limited (“Hexa Ceram”), Thailand’s largest dental laboratory, which was completed in January 2025.- The Gross Profit Margin for the six months ended 30 June 2025 was approximately 54.8%; the gross profit was approximately HK$1,005.5 million, representing an increase of approximately 10.0% as compared with the same period last year.- The Group’s EBITDA for the six months ended 30 June 2025 was approximately HK$456.7 million, representing an increase of approximately 21.6% as compared with the same period last year.- The Group’s Net Profit for the six months ended 30 June 2025 was approximately HK$288.7 million, representing an increase of approximately 34.7% as compared with the same period last year.- Basic earnings per share for the six months ended 30 June 2025 amounted to HK30.37 cents.- The Board declared an interim dividend of HK10.7 cents per ordinary share for the six months ended 30 June 2025.- For the six months ended 30 June 2025, the Group’s digital solution cases (overseas and domestic) that are produced from its Mainland China, Thailand and Vietnam production facilities increased to approximately 457,653 cases, reflecting an increase of 24.4% as compared with the same period in 2024 as a result of our clients’ continued adoption of intra-oral scanners.HONG KONG, Aug 29, 2025 - (ACN Newswire via SeaPRwire.com) - 28 August, Modern Dental Group Limited (“Modern Dental” or “the Group”, stock code: 03600.HK), a leading global dental prosthetic device provider, is pleased to announce the unaudited interim results for the six months ended 30 June 2025.During the six months ended 30 June 2025, the Group’s multi-dimensional strategies and continuous enhancement of operational efficiency and productivity as supported by the ongoing trend of digitalization in the dental industry have resulted in the Group reporting record revenues, net profit and EBITDA numbers during this period. This occurred in a period of challenging macro-economic environment with general softness in demand for dental procedures and trade war uncertainties. The Group has been proactive in its approach to deal with the unprecedented international trade environment leveraging its international production facilities located in Thailand, Vietnam and Mainland China.The global digitalization trend continues to drive consolidation within the dental prosthetics industry, enabling the Group to further expand its market share. Our ongoing digital transformation initiatives are enhancing both customer and patient experiences while improving operational efficiency, further differentiating the Group from competitors and positioning us to outperform industry peers. By leveraging on our sales and distribution network, we achieved a leading position in the dental prosthetics industry across Europe, North America, Greater China, Australia, and other countries.European BusinessesThe revenue generated from sales in the European markets accounted for the largest portion of our revenue for the period under review. During the period, the European market recorded a revenue of approximately HK$920.3 million, representing an increase of approximately HK$97.3 million as compared with the six months ended 30 June 2024. This geographic market accounted for approximately 50.2% of the Group’s total revenue. The increase in revenue from the European market was attributable to the increase in sales order volume driven by the launch of new products, such as digital dentures, and our state-of-the-art digital workflows.The Group has been the front runner providing comprehensive digital solutions offerings, ranging from numerous minimal invasive and aesthetic prosthetic solutions to intra-oral scanners and clear aligners, and is well positioned to capture the opportunities arising from the accelerated digitalization trend of the dental industry. The Group continues to aggressively gain market share from international and domestic competitors through our established dental ecosystem solutions with a focus on education and digitalization, which is available within close proximity to our clients; effectively meeting our clients’ high expectations through our various onshore and offshore resources. The Group is committed to and will continue to equip ourselves to provide the state-of-the-art digital solutions offering to the dental community in the market.North American BusinessesThe North American market represented the second largest portion of our revenue in the period under review. During the period, the North American market recorded a revenue of approximately HK$365.7 million, representing a decrease of approximately HK$19.6 million as compared with the six months ended 30 June 2024. This geographic market accounted for approximately 19.9% of the Group’s total revenue.While demand for discretionary cosmetic treatments remained soft throughout the first half of 2025, our centralized digital workflows and network-wide production oversight enabled us to deliver enhanced service quality and operational efficiencies to our North American customers. Our diversified supply bases in the US, China, Vietnam and Thailand continue to provide greater flexibility to navigate US tariff uncertainties - an advantage that sets us apart from competitors. Although digitalization of imported product lines initially drove growth in mass-market cases, implementation of the US tariff in April 2025 introduced new uncertainties and contributed to a subsequent decline in sales for our import-focused business unit.Greater China BusinessesDuring the period under review, the Greater China market recorded a revenue of approximately HK$293.2 million, representing a decrease of approximately HK$42.6 million as compared with six months ended 30 June 2024. This geographic market accounted for approximately 16.0% of the Group’s total revenue. The Mainland China market faced headwinds from the volume-based procurement policies and a prolonged period of intense price competition. This also led to aggressive promotions for dental implant treatments by Mainland China dental clinics in Hong Kong (which experienced a notable decrease in patient visits in Hong Kong). The Group’s has deliberately pivoted away from low-margin segments and stay focused on serving mid- and high-value customers, ensuring long-term sustainable profitability of the Group’s business.The Group is optimistic in its mid/long-term outlook for this market in particular where the latest procurement-related government measures are expected to (i) standardize the pricing of dental prosthetics and develop price transparency, which would level the playing field; (ii) allow the Group’s leading brand name and reputation to be a key consideration for its client and customer; and (iii) have the Group benefit from its large production team and its ability to allocate resources efficiently according to the customer or client.Australian BusinessesDuring the period under review, the Australian market recorded a revenue of approximately HK$137.9 million, representing an increase of approximately HK$10.0 million as compared with the six months ended 30 June 2024. This geographic market accounted for approximately 7.5% of the Group’s total revenue. The double-digit increase in revenue from Australia reflected a strong uptake of new digital products driven by the digitalization trend in dental industry and the revenue contribution from the acquisition of Digital Sleep which is partially offset by the depreciation of AUD against HK$ by 4.0% compared with the six months ended 30 June 2024.Other MarketsOther markets primarily include Indian Ocean countries, Malaysia, Taiwan, Singapore and Thailand. For the six months ended 30 June 2025, these markets recorded a revenue of approximately HK$117.8 million, representing an increase of approximately HK$87.9 million as compared with the six months ended 30 June 2024. This geographic market accounted for approximately 6.4% of the Group’s total revenue. The increase in revenue from other markets was primarily driven by the revenue contribution from the newly acquired Hexa Ceram.Future Prospects and StrategiesThe global macroeconomic environment remains uncertain, with geopolitical challenges creating headwinds for businesses worldwide. However, the Group’s well-diversified global presence, spanning multiple regions and markets, positions it uniquely to navigate these challenges. Unlike competitors who operate in single countries or limited regions, the Group’s balanced and diversified country risk strategy ensures resilience and stability, even in turbulent times. This global footprint, combined with our ability to adapt to local market conditions, places the Group in the best position to outperform competitors and capitalize on emerging opportunities.Digitalization is an irreversible trend driving the consolidation of the dental prosthetics industry. The Group is taking full advantage of this trend, leveraging its centralized digital workflows, advanced production capabilities, and global network to enhance operational efficiencies and deliver superior customer experiences. Our continued investment in digitalization not only strengthens our competitive edge but also accelerates the consolidation of the industry, enabling the Group to capture a larger market share.Following our landmark acquisitions in previous years, including the recent acquisition of Hexa Ceram, Thailand’s largest dental laboratory, in January 2025, the Group’s global distribution and sales network is further diversified with a larger presence in Southeast Asia region. This expansion, coupled with our diversified supply bases in the US, China, Vietnam, and Thailand, provides the Group with unparalleled flexibility to navigate challenges in connection with trade uncertainties and other geopolitical risks. With the Board’s extensive experience and determination to overcome short-term challenges, the Group is well-positioned to seize new business opportunities while remaining cautious and prudent in safeguarding shareholders’ interests.About Modern Dental GroupModern Dental Group Limited (Stock code: 03600.HK) is a leading global dental prosthetics provider, distributor and consultant with a focus on providing custom-made prostheses to customers in the growing prosthetics industry. Our product portfolio is broadly categorized into three product lines: fixed prosthetic devices, such as crowns and bridges; removable prosthetic devices, such as removable dentures; and other devices, such as orthodontic devices, sports guards, clear aligners, and anti-snoring devices.Modern Dental Group has a global portfolio of respected brands, including Labocast, Permadental and Elysee Dental in Western Europe, YZJ Dental in China, Modern Dental Lab in Hong Kong, Modern Dental USA and MicroDental in the United States, Modern Dental Pacific in Australia and New Zealand, Modern Dental SG in Singapore, Modern Dental TW in Taiwan, Apex Digital Dental in Malaysia and Hexa Ceram in Thailand. We have grown these brands by providing premium and consistent quality products and superior customer service. We have more than 80 service centers in over 28 countries and serve over 30,000 customers. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Aug 29, 2025 - (ACN Newswire via SeaPRwire.com) - China Everbright Limited ("CEL" or "the Company", stock code: 165.HK) announced its Interim results for the six months ended 30 June 2025 ("the reporting period").Highlights of the 2025 Interim Results- Strong Growth: Total income reached HK$2,068 million, representing a significant increase compared with the same period last year;- Turning Around from Loss to Profit: During the reporting period, the Company recorded a profit of HK$650 million, of which the net profit attributable to shareholders of the Company was HK$399 million, successfully turning around from a net loss;- Fundraising Increase: The total assets under management (AUM) of CEL's funds amounted to approximately HK$119.4 billion, with new fundraising amounting to approximately HK$2,741 million;- Successful Exits: The total exits from funds and principal investments amounted to HK$2.018 billionï¼›with a MOIC (multiple on invested capital) of approximately 2.78 times;- Cost Control and Efficiency Enhancement: Enhanced lean management led to a 10% year-on-year decrease in operating costs and a 38% year-on-year reduction in finance costs;- Adequate Liquidity: The Company had cash and cash equivalents of approximately HK$8.1 billion;- Steady Dividend: An interim dividend of HK$0.05 per share for 2025.In the first half of 2025, China's private equity industry entered a more stable stage of development. Leveraging its strengths as patient capital, CEL maintained strategic focus, seized market opportunities with precision, and promptly adjusted its fundraising, investment, management, and exit strategies. By consolidating its core businesses, gradually unlocking value potential, and significantly improving overall operational efficiency, the Company achieved a strong rebound in performance.During the reporting period, CEL realised total income of HK$2,068 million, representing a significant increase of HK$2,182 million from the same period last year. This was mainly due to a significant increase in investment income, which fully demonstrated the Company's sound investment vision and solid foundation in long-term investing. The Company recorded a profit of HK$650 million, of which the net profit attributable to shareholders of the Company amounted to HK$399 million, successfully turning around from a net loss attributable to shareholders of HK$1,282 million in the same period last year, representing a significant improvement in performance.Meanwhile, the Company continued to strengthen its refined management, sustaining healthy and steady business development. During the reporting period, operating costs represented a year-on-year decrease of 10%, with proactive leverage reduction measures implemented. The gearing ratio decreased by 2% compared with the end of 2024, while finance costs fell 38% year-on-year, demonstrating significant results in cost control and efficiency improvement. As at the end of June 2025, the Company had cash and cash equivalents of approximately HK$8.1 billion, representing sufficient liquidity.By concentrating its resources and business focus on high-potential products, the Company further reinforced its core business. During the reporting period, with new fundraising amounting to approximately HK$2,741 million, the total AUM of CEL’s funds amounted to approximately HK$119.4 billion, managing 72 fund products and covering primary market funds, secondary market funds, and fund of funds. During the reporting period, the Company invested in a total of 9 projects and exited, fully or partially, from 46 project.Following the practice of sharing the Company's operating results with shareholders, the Board declared interim dividend of HK$0.05 per share for 2025 (2024 interim dividend: HK$0.05 per share).Business Highlights in the First Half of 2025Firstly, CEL Harnessed the Strengths of Group-Based Operations to Enhance Fundraising SynergyIn the first half of 2025, the Company successfully launched the Huaian Hongze Guangqi Fund and the Xiamen Marine High-Tech Industrial Development Fund, with a total scale of RMB2.5 billion. The Huaian Fund targets growth-stage projects in the areas of new energy, new materials, and intelligent manufacturing, with its first round of capital contribution completed in the first half of the year. The Xiamen Marine Fund is dedicated to incubating and transforming scientific and technological innovations in the marine sector, driving the high-quality development of the marine economy. At the same time, several other funds have been approved and are progressing smoothly, following the established plan.Secondly, CEL Strengthened Core Businesses to Drive Robust Recovery in PerformanceDuring the reporting period, the Company total exits from funds and principal investments amounted to HK$2.018 billion. This include the full exit from Xpeng Motors, DAPU Telecom, and Taboola, alongside partial exit from iSoftStone, Dekon Food and Agriculture, 4Paradigm, and other projects. With a MOIC (multiple on invested capital) of approximately 2.78 times, these exits significantly boosted the DPI of multiple funds, generating substantial returns for LPs. Several listed projects, including Circle, Dekon Food and Agriculture, and NetEase Cloud Music, delivered strong market performance in the first half of the year, making notable contribution to the Company's investment returns. In the first half of the year, secondary market funds expertly capitalised on structural opportunities, achieving impressive investment performance. Notably, the Everbright Convertible Bond Opportunity Fund ranked second among similar funds in Barclays' performance rankings.Thirdly, CEL Anchored Strategy Around Scientific and Technological Innovation, With a Particular Focus on Key Industry SectorsGuided by deep industrial insight and a forward-looking strategic vision, the Company accelerated its investment activity in the first half of the year. It targeted emerging strategic industries such as artificial intelligence, chips and semiconductors, and biomedicine, with a total investment of approximately HK$264 million by funds. We have nurtured and supported a number of technology leaders, including Yangtze Memory and Wuhan Xinxin (both prominent domestic memory chip producers), HengYi Biotech (a company engaged in the research and development of innovative drug for tumors and autoimmune diseases), J-Sensor (astrategic supplier of domestic industrial automation modules and core sensors for new energy vehicles), and Tec-Do (a service provider in the field of big data and BI), among others. These investments reflect our commitment to strengthening China’s science and technology enterprises. Meanwhile, CEL supported excellent sub-funds such as Jinyi Capital and Eastern Bell Capital through its FoF platforms. These FoF investments allow us to fully leverage the advantages of resource amplification, risk diversification, and diversified returns.Fourthly, CEL Optimise Business Management to Unlock Growth MomentumIn the first half of the year, the Company continued to optimise its financing structure and took full advantage of the domestic interest rate cut cycle, issuing RMB3 billion in the first tranche of its 2025 medium-term notes at a coupon rate of 2.09% per annum — the lowest coupon rate in the Company's bond issuance history. During the reporting period, the Company's overall financing cost declined by 133 basis points year-on-year to 3.14%, while its finance costs reduced by 38% year-on-year. Operating costs also recorded year-on-year decrease of 10%, underscoring the solid progress made in reducing costs and increasing efficiency. The Company continued to optimise its risk management framework. CEL advanced the classification of risk assets, reinforced dynamic valuation management, and established a risk monitoring and early warning system, thereby improving the effectiveness of risk prevention and control across the full business cycle.Fifthly, CLE Enhanced Public Services and Upgraded Commercial Consumption.CEL leveraged its industrial strengths to enhance the quality of its products and services, catering to the growing demand for consumer services among citizens. In the commercial consumption arena, EBA successfully launched 18 "IMIX Park" shopping centres across nine cities nationwide,managing approximately 2.6 million square metres in total. These centres created approximately 37,700 jobs, attracted approximately 121 million customer visits, and hosted more than 4,500 tenant merchants in the first half of 2025. During the reporting period, Phase I of the "Zhongguancun ART PARK IMIX Parks", a flagship consumption infrastructure and urban renewal project in Beijing, opened smoothly, significantly upgrading the consumer experience and giving a strong boost to domestic demand.Sixthly, Key Portfolio Companies Maintain Stable Growth with Strong ResilienceThe core business of China Aircraft Leasing Group Holdings Limited (CALC) progressed steadily with remarkable improvements in operating quality and efficiency. The net profit attributable to shareholders recorded a year-on-year increase. As of June 30, 2025, CALC’s fleet reached 181 aircraft, leased to 41 airlines across 22 countries and regions. Everbright Senior Healthcare has been seizing the development opportunities in China's healthcare industry. As of 30 June 2025, Everbright Senior Healthcare has 237 institutions of various types in 49 cities across the country, it managed more than 30,000 beds, with occupancy rates increasing by 1.77%. Meanwhile, Terminus continued to deepen the integration of AI technology across multiple industries, driving intelligent transformation and implementing localised AI applications and digital-intelligent solutions, while receiving multiple authoritative certifications.Seventhly, CEL Strengthened ESG Framework to Promote Sustainable DevelopmentDuring the reporting period, CEL continued to promote the construction of its ESG system. the Company maintained an "A" rating in the MSCI ESG Rating and received the "BEST ESG (S)" award from the Hong Kong Investor Relations Association (HKIRA). The Company earnestly fulfilled its role as a corporate citizen by leveraging its own capabilities, organizing and participating in 46 cultural and social welfare activities in the first half of the year, serving over ten thousand people, and upholding high standards in discharging its social responsibilities.In the first half of 2025, under the strong leadership of the Everbright Group, the guidance of the Board of Directors, and the collective efforts of all employees, the Company achieved significant improvements in operational efficiency and quality, with new drivers of growth continuing to strengthen, resulting in hard-won achievements. As China's economy continues to improve and policy support intensifies, the Chinese private equity industry will embark on a new journey of high-quality development. CEL will seize market opportunities, capitalise on the momentum, and lay a solid foundation for a strong start to the 15th Five-Year Plan. In the second half of the year, CEL will continue to adhere to the overall principle of seeking progress while maintaining stability, continue to focus on revenue growth and cost control, optimise operational management, seize opportunities in key business areas such as fundraising, investment, management, and exit, leverage the cross-border platform and the synergistic advantages of the group, cultivate long-term patient capital, and advance the "five major financial initiatives", through scientific strategic planning, professional investment teams, and rigorous risk management, and continuously create value for shareholders.China Everbright Limited, https://www.everbright.com/en [SHSE:601818][HKEX:00165][OTCPK:CEVIF][OTCPK:CEVIY] Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Aug 29, 2025 - (ACN Newswire via SeaPRwire.com) - Tianneng Power International Limited (the “Company”, together with its subsidiaries, collectively referred to as the “Group” or “Tianneng”), (Stock Code: 00819.HK) releases its interim report for the six-month period ended 30 June 2025.In the first half of 2025, adhering to the Group’s vision of Strategic Guidance and Reformation Breakthrough, Tianneng coordinated the three-wheeled strategy of Industry, Technology, and Capital. While solidifying the core competency of the lead-acid battery business, the Group also accelerated the expansion of overseas markets, released the Group’s built-up potential in new-energy battery, deepened the vertical construction of the battery recycle system, and drove the diversification of products and sustainability.Within the reporting period, the Group made a strategic pivot to reduce the trade business, achieved RMB 21.168 billion in revenue for the manufacturing business, which was stable compared to the same period in 2024, accounting for approximately 87.5% of the total revenue within the sector. In terms of the trade business, the Group realized an overall revenue of RMB 30.24 billion, which represented an 89.47% decrease from the same period of 2024. Within The manufacturing sector, the high-end eco-friendly battery business remained stable, providing a resilient financial support for the Group. The emerging businesses experienced significant growth, among which the Li-ion battery business achieved a revenue of RMB 0.501 billion, representing a 174.58% growth from the same period of 2024. Within the reporting period, the Group achieved a gross profit of RMB 2.537 billion, which is stable compared to the same period of 2024. In terms of operating cash flow, the Group achieved RMB 0.891 billion of net inflow, compared to a net outflow of RMB 0.162 billion in the same period of last year. Overall, in the first half of 2025, Tianneng demonstrated strong resilience, developmental momentum, and strategic commitment in a complex external environment.Internationalisation Accelerated, Overseas Expansion Bore FruitsInternational expansion is a vital fulcrum of the Group in strengthening global competitiveness and achieving incremental leaps. In the first half of 2025, the overseas business experienced remarkable growth with continuous positive feedback, achieving a revenue of RMB 0.226 billion, representing a 75.39% growth from the same period of 2024.Within the reporting period, guided by local demands, the Group accelerated its overseas expansion with global industrial resources, and set up operational teams in countries such as Thailand, Vietnam, and Turkey while developing a sales network in major areas including the Asia-Pacific, Europe, North America, the Middle-East and Africa. In addition, the Group’s production base in Vietnam is being constructed in an orderly manner while the capacity of the assembly base is robustly released, laying the groundwork for future developments in the region. The Group has developed customised products based on specific local demands and emphasised building localised operational teams, while advancing its “Overseas Service” strategy, and systematically constructed localised standards. With these developments, the Group was able to optimise its global supply chain and release future growth potentials.Core Business Stable and Resilient, with Promising Growth MomentumWithin the reporting period, the Group pursued a path of “Stability and Growth Duality” under a complex external environment and industrial structure re-balancing. The high-end eco-friendly battery business demonstrated resilience, achieving a revenue of RMB 18.292 billion, providing the vital financial stability for the Group. The high-end eco-friendly batteries are sealed, maintenance-less lead-acid batteries built with the Group’s innovation in design and manufacturing, highly adapting to the demands of the light electric vehicle market, with their cost and performance superiority, are also widely utilised in various fields, including backup power supplies, automobile batteries, and special-purpose industrial power batteries.The Group solidified its competencies in the core business, upgraded its intelligent manufacturing capabilities, improved the operational management system, consolidated its sales network, drove product quality and comprehensive market competitiveness growth, and fortified the resilience of lead-acid batteries in a complex market environment. Within the reporting period, the Group was able to effectively upgrade its manufacturing efficiency and supply-chain resilience through utilising intelligent manufacturing systems and equipment technology upgrades, while demonstrating effective results in cost management. Through the evolution of battery technologies and product upgrades, the Group constructed a differentiated product matrix targeting major fields of usage such as light electric vehicles, data centres, automobile start-stop batteries, and industrial power batteries,driving a service system upgrade with user value at its core, and organically merged the traditional sales network with an innovative digital ecosystem.Solidifying the Diversity of Technological Road-maps and Accelerating New Business Growth In the first half of 2025, the Group committed to the development of new-energy businesses, including Li-ion batteries, solid-state batteries, hydrogen fuel cells, and sodium-ion batteries, and systematically drove innovative breakthroughs, intelligent manufacturing upgrades, user-scenario extensions, and fostered new business growth. The Group’s Li-ion batteries business mainly targets power storage and low-speed power. Within the reporting period, the Group’s power storage and low-speed power business achieved major improvements both in terms of quality and quantity. Specific markets, such as industrial batteries and automobile A/C batteries, also saw improvements in market volume. Overall, the capacity utilisation of the Group’s new-energy business was significantly enhanced, with remarkable improvements in operational efficiency and revenue, RMB 0.501 billion, a 174.58% increase from the same period of 2024.The Group’s solid-state battery also achieved intermittent success within the three dimensions of high energy density, cycle longevity, and high-rate performance. The Group also formed strategic collaborations with industry leaders in the two-wheeled vehicle market and carried out solution testing with partners targeting the low-altitude flying vehicle market. The Group continued its investment in hydrogen fuel-cells with a full-chain R&D system and an expert team, with advanced products, began testing in user-scenarios such as two-wheeled vehicles, public transportation, heavy trucks, and special-purpose machinery, and collaborated with upstream and downstream partners in constructing an application ecosystem. The Group also spearheaded the development and application of sodium-ion battery technology, and conducted experiments for key metrics such as low-temperature and cycle longevity testing for scenarios such as power storage and automobile start-stop battery in a steady manner. Through the multi-roadmap approach, and the “technology breakthrough - user scenario verification - solution delivery” process, the Group’s new-energy business growth is gradually and steadily shifting from individual verification to chain-release, firmly supporting the business momentum.Strengthening the Recycling System and Fortifying Industrial CollaborationThe battery industry is at the core of the Group’s business, which systematically constructed a full-life industry chain of manufacturing, recycling, and reusing, forming a two-railed industry system of lead-acid battery and Li-ion battery, achieving efficient recycling. Within the reporting period, the recycling business of the Group achieved a revenue of RMB 1.8 billion, a 15.82% increase compared to the same period of 2024.As a leader in the recycling industry in China, the Group is continuously building an effective recycling network with front-end reach and back-end efficiency, promoting the efficiency of waste battery recycling empowered by the collaborative effort of businesses at scale, and achieving a top-of-industry recycling ratio of crucial materials. Within the reporting period, the Group continued to enhance the granularity and precision of the recycling process from recycling, processing, and reusing, improve the differentiating system for Li-ion battery recycling, and improve the resource synergies at core regions and user scenarios. Through uninterrupted exploration of technological potential and system performance optimisation, the Group was able to gradually achieve scale advantage and economic value of the recycling system, injecting continuous momentum for the industry.Looking forward, Tianneng will drive industrial upgrades through technological innovation, empower efficient operation through digitisation, rebuild the value-chain system through ecological collaboration, and seek growth through internationalisation. The Group will solidify its competencies in the lead-acid market, accelerate the research, application, and market expansion process of new energy batteries such as Li-ion battery and solid-state battery. The Group will strengthen its capabilities in battery recycling, enhance the collaborative efficiency of industry-chain integration while expediting its expansion into overseas markets and optimising localised operation, from product to service, and develop into a new-energy battery company that is competitive with a global vision. Finally, the Group will promote the convergence between its company values and social values with a growth mindset and build a new paradigm of sustainable and high-quality growth.About Tianneng Power International LimitedTianneng Power International Limited and its subsidiaries (collectively referred to as “Tianneng” or the “Company”), founded in 1986 and headquartered in China, has developed into a leading enterprise in the new energy battery and the light electric vehicle battery industry with a comprehensive manufacturing system and technological advantage. Tianneng was listed on the Main Board of The Stock Exchange of Hong Kong Limited (Stock Code: 00819. HK) in 2007. After nearly four decades of development, Tianneng has established lead-acid batteries as its core business, focusing on the market of motive batteries for light electric vehicles, while expanding its product in automotive start-stop systems, backup power for communication base stations and other diversified scenarios. The Company is also advancing the R&D, production and sales of lithium-ion batteries, hydrogen fuel cells, sodium-ion batteries and solid-state batteries, offering multi-technology battery solutions for special industrial vehicles, energy storage systems and other applications. Additionally, Tianneng strengthens its recycling economy initiatives around its core operations. Through a dual-track system for lead and lithium recycling, the Company achieves efficient resource regeneration and reuse, building a comprehensive ecosystem for the new energy industry. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Aug 29, 2025 - (ACN Newswire via SeaPRwire.com) - Yunkang Group Limited ("Yunkang" or the "Group"; Stock Code: 2325), a leading medical operation services provider in China, has announced its interim results for the six months ended 30 June 2025 (the "Reporting Period"). The Group adopted “one horizontal, one vertical” as its core business strategy: horizontally, it extended a lean management system to advance multi-mode collaboration among medical institution alliances; vertically, it focused on specialty-specific innovation in medical diagnostics to fast-track the translation and implementation of new technologies and products. Meanwhile, the Group leveraged AI to enhance the comprehensive solutions for medical institution alliances, promoted the practical application of AI in healthcare scenarios, and continuously strengthened the value of empowering clinical practices, demonstrating strong operational resilience.In the first half of 2025, due to multiple factors, including the centralized drug-procurement program, cost controls of medical insurance, and fierce market competition, the Group’s short-term results did not meet expectations. However, the Group remained committed to product and business model innovation, and further refined the mechanisms and processes of its operational management. By adhering to lean operations, the overall performance has achieved significant improvements. During the Reporting Period, the Group’s gross profit margin reached approximately 34.0%, representing an improvement of approximately 4.4% over the overall gross profit margin for 2024. The net loss amounted to RMB55.4 million, a significant decrease of 56.1% compared to the same period last year. The joint construction business remained the Group’s largest business segment, which recorded the revenue of RMB180.3 million, accounting for 57.6% of the total revenue, increased by approximately 9.6% as compared with the same period last year, achieving significant outcomes in empowering medical alliance clients through in-depth services, paving the way for the Group’s long-term high-quality growth. During the Reporting Period, the Group’s diagnostic testing services recorded revenue of RMB313.2 millionSteadily implementing “one horizontal, one vertical” strategy, with notable achievements in hospital-enterprise partnerships“One horizontal” ——Extending lean management system to deepen diverse forms of collaboration within medical institution alliancesYunkang has been committed to developing an innovative service mode for the joint construction of medical institution alliances featuring “professionalism as the foundation, standardization as the core, digital intelligence as the means, synergization as the goal”. During the Reporting Period, the Group provided nearly 450 alliance clients with multi-scenario solutions tailored to different clinical needs, including AI+ digital intelligence solutions for medical institution alliances, comprehensive collaborations with medical laboratories, solutions for regional/pathology centers and precision medicine center, and specialty-based solutions for alliance development, among other multi-model collaboration services. By leveraging Yunkang’s strengths, the Group assisted healthcare institutions at all levels in enhancing service capabilities and expanding service coverage, established a hierarchical and coordinated healthcare service system, and promoted the development of regional hierarchical diagnosis and treatment services.During the Reporting Period, despite increasingly fierce market competition, the Group maintained solid growth in the joint construction business through continuous deep collaboration with leading hospitals and municipal and county-level hospitals, further consolidating its competitive advantage.“One vertical” ——Joint innovation platform for diagnostic testing serves as strong driver for R&DThe Group has always focused on “clinical needs”, continuously strengthening hospital-enterprise collaboration and pioneering the establishment of a joint innovation platform for diagnostic testing, driving business expansion and product competitiveness. During the Reporting Period, the Group forged joint diagnostic innovation partnerships with dozens of top-tier medical institutions nationwide, delivering a portfolio of testing products addressing multiple infectious syndromes, including respiratory tract infections, central nervous system infections, urinary tract infections, gynecological infections, and tuberculosis, as well as genetic testing products for personalized medication. Collectively, these innovative products have served nearly 300 clients across the country, and achieved sustained growth in testing revenue.During the Reporting Period, Yunkang and Guangdong Provincial People’s Hospital successively launched a series of new panel products covering respiratory tract infections, central nervous system infections, and invasive fungal infections, successfully creating a standardized incubation model for domestic hospital-enterprise research innovation and translation, as well as a “1+N” medical inspection collaboration network. Moreover, throughout the process of scientific and technological innovation, both parties have gained rich clinical experience. With the active involvement and sustained efforts of dozens of domestic diagnostic experts and scholars, they formulated the Expert Consensus on the Application of tNGS for Clinical Standardization, which was published during the Reporting Period in Chinese Journal of Laboratory Medicine, a leading journal in China’s diagnostic field. During the Reporting Period, Yunkang also maintained close collaboration with the First Affiliated Hospital of Guangzhou Medical University, one of China’s top-tier hospitals, and successfully developed a urinary tNGS product, advancing the clinical practice of precision diagnosis and treatment for urinary tract infections. Simultaneously, Yunkang partnered with the First Affiliated Hospital of Jinan University to establish a “university-hospital-enterprise joint innovation platform” and incubated and operated the “innovation project of psychiatric drug genetic testing”, which has successfully yielded genetic testing products for antidepressants, anti-anxiety drugs, and sedative-hypnotics.AI empowers multi-modal solutions for medical institution alliances, improving quality and efficiency to deepen client services During the Reporting Period, Yunkang fully employed DeepSeek and achieved digital deployment across its platforms. Centered on the core concepts of “AI+” and “precision diagnostics”, Yunkang extensively applied artificial intelligence technology across the multi-technology platforms of its medical laboratories. Taking the in-depth integration of AI technology with Yunkang pathology diagnosis platform as an example, the per-slide efficiency of AI-empowered diagnostic was continuously optimized, achieving simultaneous improvements in intelligence, efficiency, and quality. Moreover, through the deployment of intelligent applications, Yunkang realized smart online customer services and the efficient review of results and reports, which fully streamlined diagnostic service processes and improved experience and satisfaction of its client services. In the process of jointly developing new technologies and products through hospital-enterprise R&D, Yunkang’s AI technology empowered product innovation and R&D across multiple aspects, including bioinformatics analysis, report interpretation, disease risk assessment, and development and translation of novel products, by leveraging the powerful data analysis, modeling, and predictive capabilities of large-scale AI models. This has accelerated the clinical implementation.Notably, Yunkang unveiled its medical AI model “ZhiYun” developed in collaboration with Runda Medical and Huawei, spanning the entire clinical workflow from pre-diagnosis to diagnosis and post-diagnosis. It will provide more efficient and convenient support and experience across all stages of clinical medical services. Meanwhile, Yunkang signed a strategic cooperation agreement with Runda Medical to strengthen in-depth collaboration across the industrial ecosystems in “AI + IVD + healthcare services”, jointly promoting the development and application of large-scale AI models in the medical field, and providing clients with digital-intelligence healthcare solutions. In the future, “ZhiYun”, the medical AI model, will be piloted in Yunkang’s healthcare partners and gradually rolled out nationwide, to improve quality and efficiency of medical institution alliance operations.Future prospects2025 marks the final lap for implementing the 14th Five-Year Plan. China has accelerated the capacity expansion of premium healthcare resources and their extension to lower-tier markets, resulting in a more balanced regional distribution. The country has also expedited the development of medical institution alliances and driven their upgrade from “framework building” to “high-quality operation”. Clinical treatment is also shifting from “broad-spectrum therapies” to “precision medicine”, with the growth potential of the industry continuing to be realized. At the same time, AI technology has continued to empower hierarchical diagnosis and treatment services, and the industry is embracing new growth opportunities. Looking ahead, Yunkang will continue to keep pace with industry development trends and align with national policies, further strengthening the value of empowering clinical practices, and persistently exploring the “product innovation + business innovation” dual-pronged model to accelerate business development, deeply empower medical testing services, and benefit more residents.Yunkang Group Limited (Stock Code: 2325)Yunkang Group is a leading medical operation service provider in China, which started to provide standardized medical diagnostic services to medical institutions at all levels as early as 2008. Leveraging its own professional diagnostic capabilities and the nationwide service network of integrated healthcare systems, Yunkang has gradually grown to become a medical operation service platform. Meanwhile, Yunkang is a medical operation service provider in China offering a full suite of diagnostic testing services which are diagnostic outsourcing services and diagnostic testing services for medical institution alliances. Yunkang provides diagnostic services through on-site diagnostic centers to collaborative hospitals in the integrated healthcare systems in China and assists them in improving their clinical diagnosis capabilities through co-developing diagnostic centers. As of today, Yunkang has successfully provided professional services to nearly 450 on-site diagnostic centers. As of June 30, 2025, the hospitals we collaborated with were located across 31 provinces and municipalities in China. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com